ReachRxResearch
Home
Research
Sign Up
HYALURONIC ACID (HA)-INDUCED INCREASE IN ANATOMICAL ACCOMMODATION RESPONSE IN PRESBYOPIC MONKEYS
Back to Research Hub
  1. Home
  2. Research Hub
  3. HYALURONIC ACID (HA)-INDUCED INCREASE IN…

HYALURONIC ACID (HA)-INDUCED INCREASE IN ANATOMICAL ACCOMMODATION RESPONSE IN PRESBYOPIC MONKEYS

Experimental Eye Research·October 26
OphthalmologyLimited evidencePresbyopiaAnimal StudyIntravitreal InjectionViscoelastic AgentAdultHealon GVHyaluronic Acid

Summary

View source

What was studied

Whether intravitreal injection of hyaluronic acid (HA; 0.3 mL of 14 mg/mL Healon GV) in presbyopic monkeys could restore accommodative responses (lens thickening, ciliary muscle movement, choroidal movement, dioptric amplitude) compared to baseline, measured over up to 16 months post-injection using refractometry, UBM, and OCT.

Key findings

Two weeks after HA injection, accommodative amplitude increased by 1.19 ± 0.79 diopters, lens thickening by 0.24 ± 0.05 mm, forward ciliary muscle movement by 0.42 ± 0.09 mm, centrifugal choroidal movement by 0.47 ± 0.19 mm, and anterior lens surface curvature improved by 2.43 ± 0.49 mm radius of curvature; these effects were maintained up to 16 months post-injection, with no change in the untreated contralateral eye.

Study limitations

Study conducted in monkeys (n not fully reported for all endpoints; n=2 for EW stimulation subgroup), limiting direct translation to humans; pilocarpine was used pharmacologically to induce accommodation rather than natural neural stimulation for most endpoints; the study lacks a sham-injection control group.

Clinical implications

Restoring vitreous HA levels via intravitreal injection may durably improve accommodative mechanics in presbyopic eyes, suggesting a potential therapeutic avenue for presbyopia, though clinical translation requires human trials. Clinicians interested in presbyopia treatment or accommodating IOL design may watch this line of research closely.

Caveats

  • All subjects were non-human primates (monkeys); results may not translate directly to human presbyopia physiology or treatment outcomes
  • No sham-injection control was included; contralateral untreated eyes served as controls, which may not account for all systemic or procedural confounds
  • Pilocarpine was used to pharmacologically drive accommodation in most experiments, which may not fully replicate voluntary neural accommodation
Show all 4
  • The EW nucleus electrical stimulation subgroup was very small (n=2), limiting confidence in those specific findings

Related Questions

Explore related topics

intravitreal hyaluronic acid injection for presbyopia treatment in humansvitreous hyaluronic acid levels and age-related accommodative loss mechanismsaccommodating intraocular lens design and vitreous biomechanics

Publication Details

Year
2026
Journal
Experimental Eye Research
Source
View article
Keep scrolling
More content below.
Up Next